PubMed Health⌕ Search

Biomedical subjects

S Keros

Publications and source records attributed to S Keros.

3 recordsLinked to original sources

Ectopic action potential generation in cortical interneurons during synchronized GABA responses.

In the presence of 4-aminopyridine and excitatory amino acid receptor antagonists, individual neurons in brain slice preparations exhibit large gamma aminobutyric acid (GABA)-mediated responses as a consequence of synchronous GABA release from a network of interneurons. These synchronized GABA responses are frequently associated with ectopic action potentials (EAPs), which are thought to be action potentials initiated in distal axon terminals which subsequently travel antidromically toward the soma. Ectopic action potentials feature prominently in some models of epilepsy. Neocortical synchronized GABA responses propagate across the cortex, predominantly in superficial layers. The role that EAPs may play in contributing to laminar differences in the synchronized GABA response has not been addressed. Here we examined the occurrence of EAPs during synchronized GABA responses in neurons within layers I and II/III. EAPs occurred in 78% of layer I interneurons and in 25% of layer II/III interneurons (including chandelier cells). EAPs were not observed in layer II/III pyramidal neurons. The prevalence of EAPs in layer I interneurons provides a mechanism by which layer I can support both the initiation and propagation of synchronized GABA responses. Thus, layer I interneurons are a critical component of a network capable of synchronizing a propagating wave of GABA release across the neocortex.

Action Potentials↗

Potassium-coupled chloride cotransport controls intracellular chloride in rat neocortical pyramidal neurons.

Chloride (Cl(-)) homeostasis is critical for many cell functions including cell signaling and volume regulation. The action of GABA at GABA(A) receptors is primarily determined by the concentration of intracellular Cl(-). Developmental regulation of intracellular Cl(-) results in a depolarizing response to GABA in immature neocortical neurons and a hyperpolarizing or shunting response in mature neocortical neurons. One protein that participates in Cl(-) homeostasis is the neuron-specific K(+)-Cl(-) cotransporter (KCC2). Thermodynamic considerations predict that in the physiological ranges of intracellular Cl(-) and extracellular K(+) concentrations, KCC2 can act to either extrude or accumulate Cl(-). To test this hypothesis, we examined KCC2 function in pyramidal cells from rat neocortical slices in mature (18-28 d postnatal) and immature (3-6 d postnatal) rats. Intracellular Cl(-) concentration was estimated from the reversal potential of whole-cell currents evoked by local application of exogenous GABA. Both increasing and decreasing the extracellular K(+) concentration resulted in a concomitant change in intracellular Cl(-) concentration in neurons from mature rats. KCC2 inhibition by furosemide caused a change in the intracellular Cl(-) concentration that depended on the concentration of pipette Cl(-); in recordings with low pipette Cl(-), furosemide lowered intracellular Cl(-), whereas in recordings with elevated pipette Cl(-), furosemide raised intracellular Cl(-). In neurons from neonatal rats, manipulation of extracellular K(+) had no effect on intracellular Cl(-) concentration, consistent with the minimal KCC2 mRNA levels observed in neocortical neurons from immature animals. These data demonstrate a physiologically relevant and developmentally regulated role for KCC2 in Cl(-) homeostasis via both Cl(-) extrusion and accumulation.

Aging↗

Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons.

The transient outward potassium current was studied in outside-out macropatches excised from the soma of CA1 pyramidal neurons and stratum (st.) oriens-alveus inhibitory interneurons in rat hippocampal slices. Arachidonic acid dose dependently decreased the charge transfer associated with the transient current, concomitant with an increase in the rate of current inactivation. Arachidonic acid (AA) did not affect the voltage dependence of steady state inactivation but did prolong the period required for complete recovery from inactivation. The effects of AA were mimicked by the nonmetabolizable analog of AA, 5,8,11,14-eicosatetraynoic acid, suggesting that metabolic products of AA were not responsible for the observed blocking action. In addition, AA blocked st. oriens-alveus-lacunosum-moleculare interneuron transient currents but not currents recorded from basket cell interneurons. In current clamp experiments, AA was without effect on the action potential waveform of CA1 pyramidal neurons under control recording conditions. In voltage-clamp experiments, the use of a test pulse paradigm, designed to mimic the action potential voltage trajectory, revealed that the transient current normally associated with a single spike deactivates too rapidly for AA to have an effect. Transient currents activated by longer duration "action potential" waveforms, however, were attenuated by AA. Consistent with this finding was the observation that AA broadened interictal spikes recorded in the elevated [K+]o model of epilepsy. These data suggest that AA liberated from hippocampal neurons may act to block the transient current selectively in both CA1 pyramidal neurons and inhibitory interneurons and to broaden action potentials selectively under pathological conditions.

5,8,11,14-Eicosatetraynoic Acid↗